Background: Racial/ethnic disparities exist along the breast cancer continuum, including time to a diagnosis. Previous research has largely focused on patient-level factors, and less is known about the role that health care facilities may play in delayed breast cancer care.
R
acial/ethnic disparities span the breast cancer continuum. 1,2 Despite lower incidence rates, non-Hispanic (nH) black and Hispanic women are more likely to experience late-stage diagnosis [2] [3] [4] and die of breast cancer. 5, 6 The disparate experiences women face in care partially contribute to poorer clinical presentation and survival. For example, nH black and Hispanic women experience longer delays to confirmed diagnosis of breast cancer, [7] [8] [9] which has been associated with late-stage detection 10 and poorer survival. 11 Studies concerning diagnostic delays have largely focused on patient factors, [12] [13] [14] [15] [16] [17] [18] [19] including socioeconomic, health care access, and utilization.
Less is known about the role that health care facilities may play in delays. Minority and nH white patients differ in where they seek care: minority patients attend facilities with fewer resources and lower quality of care, [20] [21] which in turn may influence delays and outcomes. [22] [23] [24] For example, nH white women are more likely than nH black or Hispanic women to obtain mammograms at facilities with academic affiliation, dedicated breast radiologists, and digital mammography. 25 Facilities serving minorities and other vulnerable populations generally report longer periods of time to diagnostic resolution, 22 potentially due to limited resources and scheduling delays. Taken together, these studies suggest that racial/ethnic differences in where patients initially present with breast cancer may help to explain observed disparities in diagnostic delay.
The current study examines 3 types of facility factors that may mediate racial/ethnic disparities in time to diagnostic resolution. The first characteristic is accreditation, measured by status as a member of the National Consortium of Breast Centers (NCBC) 26 and certification as an American College of Radiology's Breast Imaging Center of Excellence program (BICOE). 27 Accrediting agencies assess facilities' quality control and assurance for staff and equipment in multiple breast cancer detection technologies (eg, mammography, breast ultrasound, magnetic resonance imaging, stereotactic biopsy) for accreditation status. Recent work has indicated that accredited hospitals are more likely than nonaccredited hospitals to meet national benchmarks for quality care (eg, Mammography Quality Standards Act guidelines 28 ). Given these resources, women receiving care from accredited facilities may be more likely to obtain a definitive diagnosis in less time. The second characteristic is facility disproportionate share hospital (DSH) status. DSH facilities are identified as serving high numbers of disadvantaged patients and providing more uncompensated care. 29 Because of limited resources, women receiving care from these facilities may experience longer time to a definitive breast cancer diagnosis. The final characteristic is coordination of care, measured by the number of facilities from medical presentation to diagnosis. Women receiving care from multiple facilities may experience longer time to a definitive diagnosis due to inadequate coordination of care. 30 
METHODS

Sample and Procedures
Study details have been described previously 31, 32 (Blinded for Review). Patients were eligible, if they were aged 30 to 79 years at diagnosis, resided in Chicago at the time of their diagnosis, were diagnosed with primary in situ or invasive breast cancer in 2005 and 2008; and reported their race/ethnicity as nH white, nH black, or Hispanic. The final interview response rate was 56% (n = 989); 849 women provided authorization and written consent to medical record abstraction. Data on facility factors and documented date of a definitive diagnosis were available for 606 patients. Women in the analytic sample were more likely to identify as nH black or Hispanic (P = 0.01) and were more likely to have screen-detected breast cancers (P < 0.0001). In addition, women in the analytic sample were less likely to have obtained care at >1 facility (32% vs. 47%; P < 0.0001). Women in the excluded and analytic samples did not significantly differ with regard to receipt of services at facilities with accreditation or DSH status (Ps = 0.45-0.70). Participants in the analytic sample reported receipt of services from 115 unique facilities (Table 1) .
Measures
Sociodemographic Measures
Race/ethnicity was based on separate self-identifications of race and Hispanic ethnicity. Standard questions were administered for individual-level household income and education. The language used to complete the survey (English or Spanish) was also recorded. Data from the 2000 US Bureau of the Census were used to define 2 variables (concentrated disadvantage and concentrated affluence) based on census tract of residence. 32 Mode of detection was defined as the self-reported method of initial awareness of breast cancer (signs or symptoms vs. screening).
Access/Utilization
Health insurance (no outpatient insurance, public insurance, private insurance), type of primary care (no regular provider or place, regular place, regular provider), number of mammograms in the past 5 years, and recency of last clinical breast examination before diagnosis were reported.
Facility Factors
The facility of medical presentation was defined with respect to certification as an NCBC facility, 26 as an American College of Radiology BICOE facility, 27 and designation as a DSH by the state of Illinois. 29 Sites that were nonhospital sites but that were public health facilities were defined as DSH for these analyses. Approximately 17% (N = 19) of facilities had BICOE certification, 4% (N = 5) had NCBC certification, and 23% (N = 26) had DSH status. BI-COE facilities were more likely to be NCBC facilities and vice versa (Table 1 ). There were no significant relationships between NCBC and BICOE certification to DSH status. The number of facilities involved from initial discovery to definitive diagnosis of their breast cancer was summed, and subsequently dichotomized as 1 versus >1 facility. Women attending accredited facilities were less likely to obtain care at multiple facilities, BICOE: 49% versus 13%, P < 0.0001; NCBC: 33% versus 18%, P = 0.02. There was no association between number of facilities and DSH status, P = 0.91.
Diagnostic Delays
Diagnostic delay was defined as >60 days between self-reported date of first medical presentation and the date of a definitive diagnosis/biopsy found in the medical record. This definition has been previously used for research and program evaluation concerning diagnostic delays. [33] [34] [35] [36] Also, previous evidence has linked 2-month delays to survival. 12 
Statistical Analysis
For patients (r1%) with missing data, racial/ethnicspecific means of variables were used for imputation. We conducted w 2 tests for racial/ethnic differences in patient and facility factors, and for relationships of patient and facility factors with diagnostic delay. Next, we compared nested logistic regression models of diagnostic delay using type 3 analyses. We conducted logistic regression with model-based standardization (predictive margins) to estimate what the disparity might be if we were able to equalize the distribution of the domains across racial/ethnic groups in the study. In addition, we compared rescaled coefficients using the method described by Karlson, Holm, and Breen. 37 
RESULTS
Minorities exhibited less screening-based detection, lower socioeconomic status (all 4 indicators), less health care access (insurance, type of primary care), and were less likely to have obtained a clinical breast examination within 1 year of their breast cancer diagnosis (Table 2) . Minorities were less likely to attend a BICOE accredited facility, but more likely to attend a DSH facility and multiple facilities ( Table 2) .
In all, 22% of women experienced a diagnostic delay (Table 3) . Racial and ethnic minorities, as well as women with lower socioeconomic status and less health care insurance were more likely to experience delays (Table 3) . Women who received care from a single facility and from facilities with BI-COE and NCBC certification were less likely to experience delays, whereas those who received care from DSH facilities were more likely to experience delays. Health care utilization was not associated with diagnostic delay.
In type 3 analysis of full and partial logistic regression models concerning diagnostic delays, the model which excluded facility factors had significantly poorer fit relative to full and other partial models (all Pr0.001). No other significant differences emerged between models (Ps = 0.20-0.55).
When examining differences between nH white and minorities, adjustment for all variables pertaining to socioeconomic status reduced the disparity by half, and adjustment for access/utilization variables accounted for roughly one-fifth of the disparity (Table 4) . Adjustment for facility factors accounted for 43% of the disparity, with BICOE certification emerging as the most important mediating factor (by itself accounting for 37% of the disparity). Simultaneous adjustment for all domains accounted for more than two-thirds of the disparity in diagnostic delay. Similar patterns emerged for nH white-nH black and nH white-Hispanic comparisons (Table 4) .
DISCUSSION
In line with previous work, we found racial/ethnic differences in where patients received care: nH whites were more likely to obtain breast cancer care from accredited and non-DSH facilities and to obtain their care within a single facility relative to nH black and Hispanic women. These factors were associated with reduced likelihood of diagnostic delays, which is in line with other work concerning between-facility effects on diagnostic delays and other cancer-related outcomes. 20, 21, 23, 24, 38, 39 Few studies, however, have directly examined the potential role of facility resources in mediating disparities in delay. One study we are aware of found that racial/ethnic disparities were attenuated when adjusting for between-facility variation in time to diagnostic resolution, 17 but did not directly examine racial/ethnic differences in where women sought care nor which components of clinics contributed to variation in time to diagnostic resolution. Our work, thus, provides an important contribution to existing literature through the direct assessment of how between-facility effects may underlie racial/ethnic breast cancer disparities.
BICOE certification emerged as a particularly important mediating factor. Patients presenting either with symptoms or via screen-detection at a BICOE facility begin their breast cancer care at a high-resource facility with all the modalities needed to do a complete diagnostic workup, including multimodality imaging and image-guided biopsy. Although a patient may still choose to go elsewhere to complete diagnostic care, the reputation that comes with BICOE certification may provide an additional incentive for patients and their providers to complete diagnostic care at that facility. Racial/ethnic minorities were more likely to present at a non-BICOE facility, and presentation at a non-BICOE facility was associated with a greater likelihood of a diagnostic delay. As a result, the difference in presentation at BICOE facilities accounted for a substantial amount of the racial/ethnic disparity in diagnostic delay. There were several limitations to the current study. Our study was set within a single, urban geographic region with unique and significant racial/ethnic inequities in women's health. 40, 41 Given this, future research is needed to confirm the generalizability of our results to other areas where health care resources may be distributed differently, including other urban areas. The current study did not use existing databases with a number of important facility factors, including the Medicare provider of service or Annual Survey of Hospitals survey. Future work is warranted to use these resources to further examine the role of facility factors in cancer disparities. Nonetheless, our study also has several strengths, including being population-based, relying on self-reported racial/ethnic data, including both patient-level and neighborhood-level data, and examination of multiple facility factors.
Timeliness, coordination, and quality of care are becoming an important part of how health care payment is being incentivized under the Patient Protection and Affordable Care Act. Research into understanding what drives timeliness can help to inform these and related policy decisions. 42 Our study specifically answers an important question regarding the potential influence of facility characteristics on delayed breast cancer diagnosis and disparities. The role of facility factors in disparities may inform the development of national strategies for quality control and assurance, [42] [43] [44] [45] including increasing access to BICOE facilities through expanding referral networks (eg, HB3673) and facilitating interorganizational coordination of care 46 through efforts such as the Bundled Payments for Care Improvement Initiative and medical home models. 47, 48 Such efforts would facilitate women's access to existing facilities with BICOE certification. At the same time, our results may inform efforts to justify capacity building for underresourced facilities, such as DSH facilities and community clinics, under the new reform, including the Capital Development-Building Capacity Grant Program. Such efforts may enable the resources necessary for these facilities to obtain BICOE certification.
